Your browser doesn't support javascript.
loading
AGuIX nanoparticles enhance ionizing radiation-induced ferroptosis on tumor cells by targeting the NRF2-GPX4 signaling pathway.
Sun, Hao; Cai, Hui; Xu, Chang; Zhai, Hezheng; Lux, François; Xie, Yi; Feng, Li; Du, Liqing; Liu, Yang; Sun, Xiaohui; Wang, Qin; Song, Huijuan; He, Ningning; Zhang, Manman; Ji, Kaihua; Wang, Jinhan; Gu, Yeqing; Leduc, Géraldine; Doussineau, Tristan; Wang, Yan; Liu, Qiang; Tillement, Olivier.
Afiliación
  • Sun H; Institute of Radiation Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300192, China.
  • Cai H; Institute of Radiation Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300192, China.
  • Xu C; Institute of Radiation Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300192, China.
  • Zhai H; Institute of Radiation Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300192, China.
  • Lux F; School of Precision Instruments and OPTO-Electronics Engineering, Tianjin University, Tianjin, 300072, China.
  • Xie Y; Institute Light and Mater, UMR5306, Lyon1 University-CNRS, Lyon University, 69100, Villeurbanne, France.
  • Feng L; Institut Universitaire de France (IUF), 75231, Paris, France.
  • Du L; Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou, 730000, China.
  • Liu Y; Department of Medical Ultrasound, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Shandong Medicine and Health Key Laboratory of Abdominal Medical Imaging, Jinan, 250014, China.
  • Sun X; Institute of Radiation Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300192, China.
  • Wang Q; Institute of Radiation Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300192, China.
  • Song H; Institute of Radiation Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300192, China.
  • He N; Institute of Radiation Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300192, China.
  • Zhang M; Institute of Radiation Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300192, China.
  • Ji K; Institute of Radiation Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300192, China.
  • Wang J; Institute of Radiation Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300192, China.
  • Gu Y; Institute of Radiation Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300192, China.
  • Leduc G; Institute of Radiation Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300192, China.
  • Doussineau T; Institute of Radiation Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300192, China.
  • Wang Y; NH TherAguix S.A.S, 29 chemin du Vieux Chêne, 38240, Meylan, France.
  • Liu Q; NH TherAguix S.A.S, 29 chemin du Vieux Chêne, 38240, Meylan, France.
  • Tillement O; Institute of Radiation Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300192, China. wangyan@irm-cams.ac.cn.
J Nanobiotechnology ; 20(1): 449, 2022 Oct 14.
Article en En | MEDLINE | ID: mdl-36242003

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Fármacos Sensibilizantes a Radiaciones / Nanopartículas / Neoplasias Límite: Humans Idioma: En Revista: J Nanobiotechnology Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Fármacos Sensibilizantes a Radiaciones / Nanopartículas / Neoplasias Límite: Humans Idioma: En Revista: J Nanobiotechnology Año: 2022 Tipo del documento: Article País de afiliación: China